Studies: Millions Could Benefit By Taking Cholesterol-Lowering Medications
BOSTON (CBS) — Millions more Americans could benefit from treatment with popular cholesterol-lowering medications, according to two new studies.
Nearly half of adults ages 40-to-75 might be eligible to take them.
Heart disease is still the number one killer of American men and women and cholesterol-lowering statins, like atorvastatin (Lipitor) and simvastatin (Zocor), have been shown to reduce heart disease in people at risk.
Before, doctors would treat patients primarily based on their cholesterol levels, but a couple of years ago, leading cardiologists urged doctors to treat patients based on their overall risk inc...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - July 15, 2015 Category: Consumer Health News Authors: mouellette2015 Tags: Health Healthwatch Heart Health Local News Seen On WBZ-TV Syndicated Local Watch Listen Atorvastatin Dr. Mallika Marshall Health News Heart Disease Lipitor National Institutes Of Health Simvastatin Statins Zocor Source Type: news
400-Pound Patient Impales Himself Twice Falling on Magazine Rack
Engine 1, an ALS engine company staffed with one paramedic and two EMTs, is dispatched to assist police with a welfare check. On arrival, the crew finds a small, one-story house with the doors locked.
After knocking on the door, a male voice is heard yelling for help. The door is immediately forced open and the crew finds a conscious obese male, lying supine on the floor, impaled by two wooden dowels of a magazine rack. The dowels are penetrating the posterior right buttock and continue through to his lower abdomen and pelvis.
The officer radios dispatch and requests Truck 1 and Rescue 1 be dispatched emergent to the scene...
Source: JEMS Special Topics - July 14, 2015 Category: Emergency Medicine Authors: Matthew Kunkle, EMT PM, CCP Tags: Case of the Month Patient Assessment Special Patients Trauma Special Challenges Bleeding Patient Care Burns & Soft Tissue Trauma Special Topics Source Type: news
400-Pound Patient Impales Himself Twice Falling on Magazine Rack
Engine 1, an ALS engine company staffed with one paramedic and two EMTs, is dispatched to assist police with a welfare check. On arrival, the crew finds a small, one-story house with the doors locked.
After knocking on the door, a male voice is heard yelling for help. The door is immediately forced open and the crew finds a conscious obese male, lying supine on the floor, impaled by two wooden dowels of a magazine rack. The dowels are penetrating the posterior right buttock and continue through to his lower abdomen and pelvis.
The officer radios dispatch and requests Truck 1 and Rescue 1 be dispatched emergent to the scene...
Source: JEMS Patient Care - July 14, 2015 Category: Emergency Medicine Authors: Matthew Kunkle, EMT PM, CCP Tags: Case of the Month Patient Assessment Special Patients Trauma Special Challenges Bleeding Patient Care Burns & Soft Tissue Trauma Special Topics Source Type: news
400-Pound Patient Impales Himself Twice Falling on Magazine Rack
Engine 1, an ALS engine company staffed with one paramedic and two EMTs, is dispatched to assist police with a welfare check. On arrival, the crew finds a small, one-story house with the doors locked.
After knocking on the door, a male voice is heard yelling for help. The door is immediately forced open and the crew finds a conscious obese male, lying supine on the floor, impaled by two wooden dowels of a magazine rack. The dowels are penetrating the posterior right buttock and continue through to his lower abdomen and pelvis.
The officer radios dispatch and requests Truck 1 and Rescue 1 be dispatched emergent to the scene...
Source: JEMS Special Topics - July 14, 2015 Category: Emergency Medicine Authors: Matthew Kunkle, EMT PM, CCP Tags: Trauma Patient Care Special Topics Source Type: news
Some Improvement in Post-ACS Outcomes with Adjunctive Ezetimibe (FREE)
By Harlan M. Krumholz, MD, SM
Dr. Krumholz is Editor-in-Chief of NEJM Journal Watch Cardiology, from which this story was adapted. See full coverage at the link below.Ezetimibe plus simvastatin is associated with better outcomes at 7 years than statin monotherapy, according to a New England … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - June 4, 2015 Category: Primary Care Source Type: news
Results from Investigational IMPROVE-IT Study of VYTORIN® (ezetimibe and simvastatin) Published in the New England Journal of Medicine
Dateline City:
KENILWORTH, N.J.
KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK),
known as MSD outside the United States and Canada, today announced that
the New England Journal of Medicine published the results
of the IMPROVE-IT trial, an investigational study comparing treatment
with VYTORIN® (ezetimibe and simvastatin) to treatment with
simvastatin alone in more than 18,000 patients presenting with acute
coronary syndromes.
Language:
English
Co...
Source: Merck.com - Product News - June 3, 2015 Category: Drugs & Pharmacology Tags: Prescription Medicine News Corporate News Latest News Source Type: news
Does Preop Statin Help Survival in CABG?
(MedPage Today) -- Study suggested simvastatin may help but other preop heart drugs weren't useful. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - June 1, 2015 Category: Cardiology Source Type: news
Cholesterol – the super-stealthy invisible illness
Sourced from The Hysterectomy Association: Hysterectomy Association - Hysterectomy Association - hysterectomy, menopause and hormone replacement therapy (hrt) information and support for women.
As far as invisible illnesses go, they don’t come much stealthier than high cholesterol. It’s easily ignored because it builds up gradually, often showing no symptoms whatsoever. A person with high or increasing cholesterol levels will most likely feel perfectly healthy. It’s a scary though that the first sign of high cholesterol may be a heart attack or stroke – and could even prove fatal!
Fortunately, medical professionals...
Source: The Hysterectomy Association - March 26, 2015 Category: OBGYN Authors: Linda Parkinson-Hardman Tags: Health Conditions cholesterol invisible illness Source Type: news
Micro Labs recalls 54,096 bottles of cholesterol drug in US
Micro Labs is voluntarily recalling 54,096 bottles of Simvastatin Tablets, a drug for lowering cholesterol, in the US market for failing to meet specifications. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 19, 2015 Category: Pharmaceuticals Source Type: news
New Analysis from Investigational IMPROVE-IT Study Shows VYTORIN® (ezetimibe/simvastatin) Reduced Total (Initial and Recurrent) Cardiovascular Events More than Simvastatin Alone in Patients Presenting with Acute Coronary Syndromes
Dateline City:
SAN DIEGO
SAN DIEGO--(BUSINESS WIRE)--Merck (NYSE:MRK),
known as MSD outside the United States and Canada, today announced
results from a pre-specified exploratory analysis of the investigational
IMPROVE-IT study of more than 18,000 patients presenting with acute
coronary syndromes.
Language:
English
Contact:
MerckMedia:Pamela Eisele, 267-305-3558orMichael Close, 267-305-1211orInvestor...
Source: Merck.com - Product News - March 16, 2015 Category: Drugs & Pharmacology Tags: Prescription Medicine News Corporate News Latest News Source Type: news
A New Class Of Experimental Cholesterol Drugs Are Outperforming Traditional Statins
SAN DIEGO (AP) — New research boosts hope that a highly anticipated, experimental class of cholesterol drugs can greatly lower the risk for heart attacks, death and other heart-related problems. The government will decide this summer whether to allow two of these drugs on the market.
People taking one of these drugs had half the risk of dying or suffering a heart problem compared to others who were given usual care — typically one of the statin drugs such as Lipitor or Zocor, doctors found. Many people cannot tolerate statins or get enough help from them, so new medicines are badly needed.
The results are "really imp...
Source: Science - The Huffington Post - March 16, 2015 Category: Science Source Type: news
New Data from IMPROVE-IT Study of VYTORIN® (ezetimibe/simvastatin) and TRA 2ºP TIMI 50 Study of ZONTIVITY® (vorapaxar) to be Presented at American College of Cardiology Scientific Sessions
Dateline City:
KENILWORTH, N.J.
Investigational data from IMPROVE-IT to be announced in Featured Clinical Research Session II
KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada,
announced today that new data from two trials of the company’s
cardiovascular medicines will be presented at the 2015 American College
of Cardiology Annual Scientific Sessions (ACC.15), March 14-16 in San
Diego.
Language:
...
Source: Merck.com - Product News - February 25, 2015 Category: Drugs & Pharmacology Tags: Prescription Medicine News Corporate News Latest News Source Type: news
Do you take medication for high cholesterol?
Sourced from The Hysterectomy Association: Hysterectomy Association - Hysterectomy Association - hysterectomy, menopause and hormone replacement therapy (hrt) information and support for women.
6 out of every 10 people in the UK have raised cholesterol levels. Over time, cholesterol can build up in the arteries – so without treatment, high cholesterol levels can lead to serious health issues, including heart attacks, strokes and angina.
In the UK alone, 6 – 7 million people are taking prescribed medicines called statins to help lower their cholesterol levels. Some commonly prescribed statins in the UK include simvastat...
Source: The Hysterectomy Association - February 13, 2015 Category: OBGYN Authors: Linda Parkinson-Hardman Tags: Latest News Source Type: news
